US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Nasdaq Biotechnology ETF

34.75

+0.38001.11%

Post-market: 34.750.00000.00%16:15 EDT

Volume:100.22K

Turnover:3.46M

Market Cap:107.73M

PE:- -

High:34.80

Open:34.53

Low:34.07

Close:34.37

52wk High:36.84

52wk Low:25.00

Shares:3.10M

Float Shares:3.10M

Volume Ratio:1.32

T/O Rate:3.23%

Dividend:0.39

Dividend Rate:1.13%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Moderna Inc. Stock Rises 6.9%, Outperforms Peers

Vortex Energy Launches Study on Natural Hydrogen and Helium at Robinsons River Salt Project

Nurix, Gilead Extend Research Term for Oncology Program by Two Years for $10 Million Fee

Nurix Extends Gilead Collaboration for Oncology Program

CSPC Pharma to Unveil Eight New Clinical Trial Advances at 2026 ESMO Congress

Nurix - Eligible for up to $1.30 Bln in Total Payments as of May 31, 2026

THOMSON REUTERS

Nurix - Eligible for Mid-Single-Digit to Low-Teens Percentage Tiered Royalties

THOMSON REUTERS

Nurix - to Receive $10 Mln Research Term Extension Fee

THOMSON REUTERS

Nurix - Retains Co-Development and 50/50 Profit Sharing Options on Two U.S. Programs

THOMSON REUTERS

Gilead CEO Daniel O’Day Disposes of USD 2,216,507.50 in Common Shares

Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors

Amgen Inc. Stock Underperforms Friday When Compared to Competitors

Legend Biotech Faces Pressure From Rivals Ahead of Key FDA Decision, UBS Says

MT Newswires Live

Amgen’s Evolocumab Study Signals Quiet Efficiency Gains for Cholesterol Franchise

Analysts Have Conflicting Sentiments on These Healthcare Companies: TransMedics Group (TMDX), Regeneron (REGN) and Tarsus Pharmaceuticals (TARS)

Piper Sandler Remains a Buy on Regeneron (REGN)

Major Drugmakers Turn to China for Licensing Deals

Sanofi, Regeneron's Dupixent Successors Might Fall Short of Rivals

Analysts’ Top Healthcare Picks: Regeneron (REGN), Idexx Laboratories (IDXX)

Vertex Minerals lodges 2026 corporate governance statement with ASX

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/IBBQ/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBBQ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","market":"US","secType":"STK","nameCN":"Invesco Nasdaq Biotechnology ETF","latestPrice":34.75,"timestamp":1791230400000,"preClose":34.37,"halted":0,"volume":100219,"hourTrading":{"tag":"盘后","latestPrice":34.75,"preClose":34.75,"latestTime":"16:15 EDT","volume":155,"amount":5386.25,"timestamp":1791231300300,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.011056153622345143,"floatShares":3100001,"shares":3100001,"eps":0,"marketStatus":"Post-Mkt","change":0.38,"latestTime":"10-05 19:07:09 EDT","open":34.53,"high":34.8,"low":34.07,"amount":3459472,"amplitude":0.021239,"askPrice":35.09,"askSize":8500,"bidPrice":34.75,"bidSize":5,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791244800000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":34.37,"sharesOutstanding":2520001,"nav":34.4248,"aum":106440372.14,"dividendRate":0.011275,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":34.37,"preClose":34.37,"latestTime":"07:35 EDT","volume":1,"amount":34.37,"timestamp":1791200149459,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":34.75,"preClose":34.75,"latestTime":"16:15 EDT","volume":155,"amount":5386.25,"timestamp":1791231300300,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.31821,"impliedVol":0.073,"impliedVolPercentile":0.1833},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","floatShares":3100001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.31821,"shares":3100001,"dividePrice":0.3918,"high":34.8,"amplitude":0.021239,"preClose":34.37,"low":34.07,"week52Low":25,"pbRate":"--","week52High":36.84,"institutionHeld":0,"latestPrice":34.75,"committee":-0.998824,"eps":0,"divideRate":0.011275,"volume":100219,"delay":0,"ttmEps":0,"open":34.53,"prevYearClose":28.3962,"prevWeekClose":34.37,"prevMonthClose":35.14,"prevQuarterClose":35.14,"fiveDayClose":35.28,"twentyDayClose":36.05,"sixtyDayClose":33.09},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBBQ\",params:#limit:5,,,undefined,":[{"date":"2026-09-21","symbol":"IBBQ","amount":0.23037,"announcedDate":"2026-09-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-21","defaultRemindTime":1789997400000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-25","payableDate":"2026-09-21","currency":"USD","dateTimestamp":1789963200000,"payDate":"2026-09-25"},{"date":"2026-06-22","symbol":"IBBQ","amount":0.03422,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"IBBQ","amount":0.03609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"IBBQ","amount":0.0906,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"IBBQ","amount":0.09576,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBBQ\",market:\"US\",,,undefined,":[{"executeDate":"2021-09-20","recordDate":"2021-09-21","paymentDate":"2021-09-30","value":0.04324,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-31","value":0.10511,"currency":"USD"},{"executeDate":"2022-03-21","recordDate":"2022-03-22","paymentDate":"2022-03-31","value":0.03778,"currency":"USD"},{"executeDate":"2022-06-21","recordDate":"2022-06-22","paymentDate":"2022-06-30","value":0.04264,"currency":"USD"},{"executeDate":"2022-09-19","recordDate":"2022-09-20","paymentDate":"2022-09-23","value":0.03769,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBBQ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBBQ\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673084939","title":"Moderna Inc. Stock Rises 6.9%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2673084939","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673084939?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:33","pubTimestamp":1791232380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. advanced 6.9% to $203.21 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.1% to 27,477.31 and the Dow Jones Industrial Average rising 0.2% to 51,267.90.This was the stock's second consecutive day of gains.Moderna Inc. closed 2.7% below its 52-week high of $208.90, which the company reached on September 29th.The stock outperformed some of its peers, as Johnson & Johnson fell 1.2% to $252.93, Pfizer Inc. fell 1.4% to $27.41, and Gilead Sciences Inc. fell 0.08% to $144.63.Trading volume totaled 18.8 million, compared to the 50-day average of 20.1 million.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","LU1057294990.SGD","BK4139","BK4588","LU1674673428.USD","BK4578","GNOM","LU0861579265.USD","BK4568","MRNX","TBXU","LU2112291526.USD","BK4551","LU1934455277.USD","TMED","LU1066051498.USD","MRNY","WDNA","MEDI","LU0965509101.SGD","LU1037948897.HKD","IBBQ","IE00B19Z3B42.SGD","BK4532","IBB","GILD","BIB","LGHT","MRNA","BK4566","LU1061106388.HKD","BK4585","LU0109394709.USD","BBH","BMED","LU0234570918.USD","LU1839511570.USD","LU2324357040.USD","SG9999015945.SGD","IDNA","IE00BZ1G4Q59.USD","LU1778281490.HKD","LU2087621335.USD","LU0965509010.AUD","LU1674673691.USD","SG9999015952.SGD","BK4533","IE00B7SZLL34.SGD","LU2357627491.SGD","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673086684","title":"Vortex Energy Launches Study on Natural Hydrogen and Helium at Robinsons River Salt Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2673086684","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673086684?lang=en_us&edition=fundamental","pubTime":"2026-10-06 00:38","pubTimestamp":1791218328,"startTime":"0","endTime":"0","summary":"Vortex Energy Corp. ( ($TSE:VRTX) ) has issued an update. Vortex Energy Corp. has commissioned Lonquist Field Service (Canada), ULC to conduct a de...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vortex-energy-launches-study-on-natural-hydrogen-and-helium-at-robinsons-river-salt-project?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vortex-energy-launches-study-on-natural-hydrogen-and-helium-at-robinsons-river-salt-project?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1778281490.HKD","IE00B19Z9Z06.USD","LU0417517546.SGD","IE0009355771.USD","SG9999001176.SGD","LU0058720904.USD","LU2237438978.USD","PBE","LU2362541513.USD","IE0002270589.USD","IE00BZ9MQY76.HKD","LU1585245621.USD","IE00B894F039.SGD","IE00B4R5TH58.HKD","IE0002141913.USD","LU0234570918.USD","BK4533","BK4532","IBBQ","IE00BJT1NW94.SGD","LU0109394709.USD","HYDR","LU2468319806.SGD","LU2362541273.HKD","SGXZ57979304.SGD","LU2362540622.SGD","BBH","BK4588","GNMX","LU1093756168.USD","VRTX","LU2089984988.USD","LU0889565916.HKD","IE00B19Z9P08.USD","IE00B19Z3581.USD","BK4585","LU0320765992.SGD","BIB","TBXU","IE00BFTCPJ56.SGD","BK4139","LU0079474960.USD","IDNA","LU2236285917.USD","LU2456880835.USD","IBB","BK4567","LU1035775433.USD","LU2324357040.USD","SG9999013999.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673704303","title":"Nurix, Gilead Extend Research Term for Oncology Program by Two Years for $10 Million Fee","url":"https://stock-news.laohu8.com/highlight/detail?id=2673704303","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673704303?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:03","pubTimestamp":1791198202,"startTime":"0","endTime":"0","summary":"Nurix, Gilead extend research term for oncology program by two years for $10 million feeNurix Therapeutics extended the research term for an undisclosed oncology program under its strategic collaborat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDL7nTmpm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002270589.USD","SG9999015986.USD","LU0109394709.USD","LU0320765992.SGD","IE00B3T34201.USD","LU0965509283.SGD","SG9999015978.USD","BBH","LU0965509010.AUD","LU0965509101.SGD","LU1066051498.USD","IE00BN0W2W23.USD","IE00BQXX3D17.EUR","IBBQ","BK4566","MEDI","GILD","LU1037948897.HKD","LU1934455194.USD","SG9999015945.SGD","BIB","BK4568","IE00BZ1G4Q59.USD","BMED","LU0058720904.USD","LU1037948541.HKD","LU2210150020.SGD","SG9999014021.USD","IBB","LU2087621335.USD","BK4585","BK4578","IE00BQXX3F31.USD","LU2468319806.SGD","LU1430594728.SGD","LU1839511570.USD","LU0289739699.SGD","LU0859254822.USD","LU1057294990.SGD","LU1934455277.USD","TBXU","LU0314104364.USD","BK4583","LU0882574055.USD","BCDF","BK4112","NDAQ","TMED","LU0861579265.USD","NRIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673704306","title":"Nurix Extends Gilead Collaboration for Oncology Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2673704306","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673704306?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:03","pubTimestamp":1791198199,"startTime":"0","endTime":"0","summary":"BRIEF-Nurix Extends Gilead Collaboration For Oncology ProgramOct 5 (Reuters)-Nurix Therapeutics, Inc.NRIX.O:NURIX THERAPEUTICS ANNOUNCES SECOND RESEARCH TERM EXTENSION FOR ONCOLOGY PROGRAM UNDER COLLA","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA7MVP3J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","LU1585245621.USD","IE00BSNM7G36.USD","LU0058720904.USD","LU0320765992.SGD","LU1037948897.HKD","LU1057294990.SGD","LU1934455863.HKD","LU2357627491.SGD","LU1066053197.SGD","TMED","LU0965509283.SGD","LU0965509101.SGD","SG9999015952.SGD","LU0861579265.USD","LU0965508806.USD","LU2468319806.SGD","SG9999015945.SGD","BIB","LU0965509010.AUD","LU1674673691.USD","LU0109394709.USD","MEDI","BK4566","TBXU","LU1571399168.USD","LU2324357040.USD","IE00B7SZLL34.SGD","BMED","BBH","IE00B3T34201.USD","LU1023059063.AUD","IBB","LU0859254822.USD","SG9999015978.USD","LU1839511570.USD","GILD","BK4139","IE00BKVL7J92.USD","LU2087621335.USD","IBBQ","IE00B19Z3B42.SGD","IE0002270589.USD","NRIX","LU2089984988.USD","LU1934455277.USD","BK4550","LU0122379950.USD","LU1934455194.USD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170526775","title":"CSPC Pharma to Unveil Eight New Clinical Trial Advances at 2026 ESMO Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=1170526775","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170526775?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:00","pubTimestamp":1791198018,"startTime":"0","endTime":"0","summary":"CSPC Pharma (01093) has announced that the group will present 8 latest clinical trial advances at the European Society for Medical Oncology (ESMO) Annual Congress, taking place in Madrid, Spain from...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1226287792.SGD","IE00BZ08YT58.USD","IE00BZ08YR35.GBP","LU2039709279.SGD","IE00B5MMRT66.SGD","IE00BZ08YS42.EUR","IE00B543WZ88.USD","KURE","IE0008368742.USD","IBBQ","SG9999004220.SGD","LU1993786604.SGD","HK0000165453.HKD","BK1515","LU1328277881.USD","LU1813983027.USD","LU1960683339.HKD","MDTX","LU0501845795.SGD","LU0880133367.SGD","PSYK","LU0314109678.HKD","BK1191","LU1226287529.USD","LU1226288170.HKD","LU0315179316.USD","LU1008478684.HKD","LU0326950275.SGD","LU1226287875.USD","IE00B031HY20.USD","LU0067412154.USD","LU1152091168.USD","IBBJ","LU1226288253.USD","LU0140636845.USD","LU1807302812.USD","LU0072913022.USD","LU1152091754.HKD","LU1951186391.HKD","BK1521","BMED","IE0008369823.USD","01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673704828","title":"Nurix - Eligible for up to $1.30 Bln in Total Payments as of May 31, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2673704828","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673704828?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:00","pubTimestamp":1791198000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA7MVP3J:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDI","IE00B3T34201.USD","BBH","LU1778281490.HKD","IE00BKVL7J92.USD","LU1066053197.SGD","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","IBBQ","LU0965509283.SGD","LU1037948897.HKD","LU1023059063.AUD","BK4566","LU1585245621.USD","SG9999015978.USD","BMED","IBB","IE00BZ1G4Q59.USD","LU0823416689.USD","LU1061106388.HKD","LU1839511570.USD","BK4583","BK4139","BK4585","BK4532","LU0234570918.USD","LU0859254822.USD","LU1571399168.USD","LU2089984988.USD","LU0320765992.SGD","LU0058720904.USD","NRIX","LU1934455277.USD","IE00BSNM7G36.USD","LU0114720955.EUR","LU2112291526.USD","BK4578","LU2324357040.USD","LU0122379950.USD","LU1934455194.USD","BK4550","GILD","TMED","BK4588","LU0861579265.USD","LU0289739699.SGD","TBXU","BIB","BK4568","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673048487","title":"Nurix - Eligible for Mid-Single-Digit to Low-Teens Percentage Tiered Royalties","url":"https://stock-news.laohu8.com/highlight/detail?id=2673048487","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673048487?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:00","pubTimestamp":1791198000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA7MVP3J:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0002270589.USD","LU0122379950.USD","LU0965509101.SGD","BK4566","GILD","IE00B19Z3581.USD","TMED","TBXU","BMED","LU1037948897.HKD","LU0965509283.SGD","LU2089984988.USD","SG9999015986.USD","LU0889565916.HKD","LU0965509010.AUD","LU0320765992.SGD","LU0861579265.USD","LU1674673428.USD","SG9999015945.SGD","IE00BSNM7G36.USD","LU1066053197.SGD","LU0289739699.SGD","LU2087621335.USD","BK4568","MEDI","LU1037948541.HKD","BIB","IE00B3T34201.USD","LU1571399168.USD","IE00B19Z3B42.SGD","SG9999015952.SGD","IBB","LU1778281490.HKD","LU1839511570.USD","NRIX","LU1066051498.USD","LU0234570918.USD","BBH","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU1057294990.SGD","BK4550","LU1934455194.USD","LU1934455863.HKD","LU2468319806.SGD","LU1430594728.SGD","LU0859254822.USD","LU1023059063.AUD","LU0823416689.USD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673048127","title":"Nurix - to Receive $10 Mln Research Term Extension Fee","url":"https://stock-news.laohu8.com/highlight/detail?id=2673048127","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673048127?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:00","pubTimestamp":1791198000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA7MVP3J:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0965509010.AUD","LU0823416689.USD","IBB","LU1778281490.HKD","BK4566","LU1571399168.USD","LU1934455863.HKD","LU0320765992.SGD","LU1934455194.USD","LU1674673428.USD","SG9999015952.SGD","BMED","IE00BSNM7G36.USD","LU1430594728.SGD","TBXU","LU0965509101.SGD","BK4550","LU0965509283.SGD","LU0889565916.HKD","LU1037948541.HKD","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","IE0002270589.USD","LU2468319806.SGD","IE00B19Z3581.USD","LU1057294990.SGD","LU1066053197.SGD","LU0122379950.USD","LU1066051498.USD","BIB","LU2087621335.USD","IE00BZ1G4Q59.USD","LU0234570918.USD","IE00B3T34201.USD","TMED","NRIX","LU1023059063.AUD","SG9999015986.USD","LU1037948897.HKD","SG9999015945.SGD","BBH","GILD","MEDI","LU0289739699.SGD","LU0861579265.USD","LU0859254822.USD","LU2089984988.USD","IBBQ","BK4568","LU1839511570.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673021701","title":"Nurix - Retains Co-Development and 50/50 Profit Sharing Options on Two U.S. Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2673021701","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673021701?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:00","pubTimestamp":1791198000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA7MVP3J:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999015945.SGD","LU1934455194.USD","BK4578","LU1571399168.USD","LU0889565916.HKD","LU0859254822.USD","NRIX","TMED","BK4566","BBH","LU0320765992.SGD","LU0965509283.SGD","LU2468319806.SGD","BK4583","IE00B19Z3B42.SGD","LU0058720904.USD","LU1066053197.SGD","BK4532","LU1061106388.HKD","LU1057294990.SGD","LU0882574055.USD","LU1037948541.HKD","LU0861579265.USD","LU1066051498.USD","BIB","BMED","SG9999015986.USD","LU0122379950.USD","BK4568","LU1839511570.USD","IBB","LU1934455277.USD","TBXU","IBBQ","IE0002270589.USD","IE00BSNM7G36.USD","LU1778281490.HKD","GILD","IE00B3T34201.USD","LU2087621335.USD","BK4585","LU1430594728.SGD","LU0289739699.SGD","MEDI","LU0109394709.USD","IE00BZ1G4Q59.USD","LU1037948897.HKD","LU0965509010.AUD","SG9999015978.USD","LU0965509101.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672749473","title":"Gilead CEO Daniel O’Day Disposes of USD 2,216,507.50 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2672749473","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672749473?lang=en_us&edition=fundamental","pubTime":"2026-10-03 04:42","pubTimestamp":1790973757,"startTime":"0","endTime":"0","summary":"Gilead CEO Daniel O’Day disposes of USD 2,216,507.50 in common sharesGilead Sciences Chairman and CEO Daniel Patrick O’Day sold 15,000 common shares on Oct. 1, 2026.Sales were priced at USD 147.719 an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL7B1xgm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gilead CEO Daniel O’Day Disposes of USD 2,216,507.50 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","LU0889565916.HKD","BMED","GILD","IE00B19Z3581.USD","LU1066051498.USD","IE0002270589.USD","LU1934455277.USD","BBH","BIB","LU1037948897.HKD","IE00BKVL7J92.USD","LU2357627491.SGD","LU2468319806.SGD","LU0823416689.USD","SG9999015986.USD","BK4578","LU1571399168.USD","SG9999015978.USD","LU2089984988.USD","TMED","LU1430594728.SGD","LU1934455194.USD","MEDI","BK4588","LU0320765992.SGD","LU0861579265.USD","LU1674673428.USD","BK4585","LU0109394709.USD","LU1023059063.AUD","BK4532","LU0058720904.USD","LU2087621335.USD","LU0114720955.EUR","LU0965509101.SGD","LU1585245621.USD","LU0289739699.SGD","LU1934455863.HKD","IBBQ","LU0234570918.USD","IE00B19Z3B42.SGD","LU0882574055.USD","BK4550","IE00BSNM7G36.USD","LU0859254822.USD","LU0965508806.USD","TBXU","LU1778281490.HKD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672749136","title":"Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672749136","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672749136?lang=en_us&edition=fundamental","pubTime":"2026-10-03 04:35","pubTimestamp":1790973300,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  slid 1.87% to $144.74 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.73% to 7,722.72 and the Dow Jones Industrial Average  rising 0.49% to 51,176.96.This was the stock's fourth consecutive day of losses.Gilead Sciences Inc. closed 7.98% below its 52-week high of $157.29, which the company achieved on February 11th.The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson  fell 1.02% to $256.03, Pfizer Inc.  fell 1.14% to $27.80, and Abbott Laboratories  rose 0.84% to $97.50.Trading volume  remained 1.3 million below its 50-day average volume of 6.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 2, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","LU0889565916.HKD","BMED","GILD","IE00B19Z3581.USD","BK4568","IE0002270589.USD","LU1066051498.USD","LU1934455277.USD","BBH","BIB","LU1037948897.HKD","IE00BKVL7J92.USD","LU2357627491.SGD","LU2468319806.SGD","LU0823416689.USD","SG9999015986.USD","SG9999015952.SGD","BK4578","IE00BZ1G4Q59.USD","LU1571399168.USD","LU1674673691.USD","LU2089984988.USD","SG9999015978.USD","TMED","LU0965509010.AUD","LU1430594728.SGD","LU1934455194.USD","MEDI","BK4588","IE00B7SZLL34.SGD","LU0320765992.SGD","LU0861579265.USD","LU1674673428.USD","BK4585","SG9999015945.SGD","BK4583","LU0109394709.USD","LU1023059063.AUD","LU1839511570.USD","LU1037948541.HKD","LU1057294990.SGD","BK4532","LU0058720904.USD","LU0122379950.USD","LU1061106388.HKD","LU0114720955.EUR","LU2087621335.USD","LU0965509101.SGD","LU1585245621.USD","LU0289739699.SGD","LU1934455863.HKD","IBBQ","LU0234570918.USD","IE00B19Z3B42.SGD","BK4139","BK4566","BK4550","IE00BSNM7G36.USD","IE00B3T34201.USD","LU0882574055.USD","LU0965509283.SGD","LU1066053197.SGD","LU2112291526.USD","LU0859254822.USD","LU0965508806.USD","TBXU","LU1778281490.HKD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672749900","title":"Amgen Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672749900","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672749900?lang=en_us&edition=fundamental","pubTime":"2026-10-03 04:34","pubTimestamp":1790973240,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  slipped 1.04% to $403.04 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.73% to 7,722.72 and the Dow Jones Industrial Average  rising 0.49% to 51,176.96.This was the stock's third consecutive day of losses.Amgen Inc. closed 9.84% short of its 52-week high of $447.03, which the company achieved on August 25th.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson  fell 1.02% to $256.03, Pfizer Inc.  fell 1.14% to $27.80, and AbbVie Inc.  rose 1.11% to $262.82.Trading volume  eclipsed its 50-day average volume of 2.9 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 2, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1983299246.USD","TBXU","LU2468319806.SGD","IE00BJT1NW94.SGD","PBE","LU1057294990.SGD","LU2089984988.USD","LU2242652126.USD","LU1061106388.HKD","LU1571399168.USD","IE0009355771.USD","BK4599","LU0868494617.USD","BK4533","BK4585","AMGN","BK4139","IE00BFTCPJ56.SGD","IBBQ","BIB","LU2112291526.USD","LU0289739699.SGD","LU0889565916.HKD","LU0122379950.USD","LU1023059063.AUD","IE00BJJMRZ35.SGD","PJP","BK4534","IBB","LU0058720904.USD","LU2242646821.SGD","BK4588","04332","BK4581","BBH","BK4566","IE0002141913.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","SG9999001440.SGD","LU0320765992.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672034743","title":"Legend Biotech Faces Pressure From Rivals Ahead of Key FDA Decision, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2672034743","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672034743?lang=en_us&edition=fundamental","pubTime":"2026-10-03 01:05","pubTimestamp":1790960723,"startTime":"0","endTime":"0","summary":"Legend Biotech's (LEGN) multiple myeloma therapy Carvykti is facing growing competitive pressure as Gilead Sciences' (GILD) anito-cel approaches a potential approval and Johnson & Johnson's (JNJ) Tec-","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IBBQ","IE00B42XCP33.USD","BK4504","JNJ","LU0545039389.USD","MEDI","GDOC","BIB","LU1162221912.USD","LU0320765992.SGD","IE00BLSP4452.SGD","VHT","BMED","FHLC","LU1585245621.USD","LU0345769631.USD","BK4550","LABU","LU0859254822.USD","PJP","XBI","LU0345770308.USD","TRUH","FTXH","LU0889566641.SGD","TMED","XLV","IBB","IE0034235303.USD","TBXU","MEDX","GILD","IHE","JDOC","CANC","LU1261432733.SGD","LU1221951046.USD","MEMS","IYH","IE00BLSP4239.USD","LEGN","IXJ","BBH","LU0426417589.USD","SG9999001440.SGD","IE00BKVL7J92.USD","LU1057294990.SGD","RXL","LU0545562505.USD","LU2129689605.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672174313","title":"Amgen’s Evolocumab Study Signals Quiet Efficiency Gains for Cholesterol Franchise","url":"https://stock-news.laohu8.com/highlight/detail?id=2672174313","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672174313?lang=en_us&edition=fundamental","pubTime":"2026-10-03 00:30","pubTimestamp":1790958636,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen’s AMGN Evolocumab Study Highlights Subtle Edge in Cholesterol Drug Del...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgens-evolocumab-study-signals-quiet-efficiency-gains-for-cholesterol-franchise?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgens-evolocumab-study-signals-quiet-efficiency-gains-for-cholesterol-franchise?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2242646821.SGD","LU1983299246.USD","IE00B2B36J28.USD","LU1571399168.USD","IE00BFTCPJ56.SGD","LU1061106388.HKD","AMGN","LU0058720904.USD","IE00BJT1NW94.SGD","BK4139","BK4599","IE0009355771.USD","LU2468319806.SGD","PJP","BBH","IBBQ","BK4534","LU0320765992.SGD","BK4581","LU0868494617.USD","LU1057294990.SGD","LU0122379950.USD","BIB","LU2242652126.USD","LU0109394709.USD","IE00B4R5TH58.HKD","LU0889565916.HKD","BK4533","IE00BJJMRZ35.SGD","BK4585","LU0289739699.SGD","BK4588","LU2112291526.USD","IE0002141913.USD","BK4566","LU2089984988.USD","IBB","LU1023059063.AUD","TBXU","SG9999001440.SGD","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672714416","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: TransMedics Group (TMDX), Regeneron (REGN) and Tarsus Pharmaceuticals (TARS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672714416","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672714416?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:30","pubTimestamp":1790944215,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on TransMedics Group (TMDX), Regeneron (REGN) and Tar...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-transmedics-group-tmdx-regeneron-regn-and-tarsus-pharmaceuticals-tars-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-transmedics-group-tmdx-regeneron-regn-and-tarsus-pharmaceuticals-tars-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","LU2324357040.USD","BK4585","LU0289739699.SGD","LU2362540622.SGD","LU2362541513.USD","LU0109394709.USD","LU2065731478.USD","LU0889565916.HKD","LU2237438978.USD","LU0823416689.USD","LU2468319806.SGD","BBH","BK4588","LU2362541273.HKD","XBI","LU2023250504.SGD","BK4581","LABU","LU0823434583.USD","LU1917777945.USD","HCSG","LU0823434740.USD","TARS","TBXU","LU1974910355.USD","LU0053666078.USD","IBBQ","LU2106854487.HKD","LU0029874061.USD","LU0128526141.USD","BK4082","LU0058720904.USD","REGN","BK4137","BK4139","TMDX","LU0882574055.USD","XLV","IBB","LU2089984988.USD","LU0114720955.EUR","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672071900","title":"Piper Sandler Remains a Buy on Regeneron (REGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672071900","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672071900?lang=en_us&edition=fundamental","pubTime":"2026-10-02 19:35","pubTimestamp":1790940929,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Biren Amin maintained a Buy rating on Regeneron today and set a price target of $854.00. Amin covers the Healthcare sector, f...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-remains-a-buy-on-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-remains-a-buy-on-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TBXU","LU2468319806.SGD","LU2023250504.SGD","LU2324357040.USD","REGN","LU0053666078.USD","LU0889565916.HKD","LU0114720955.EUR","LU1917777945.USD","LU1974910355.USD","BK4588","BK4581","LU2362541513.USD","IBBQ","LU2237438978.USD","LU0823434583.USD","LU2362540622.SGD","LU0320765992.SGD","LU0058720904.USD","XLV","XBI","BK4139","LU2362541273.HKD","LU0109394709.USD","LABU","BBH","LU0882574055.USD","LU0823416689.USD","LU0823434740.USD","LU2106854487.HKD","LU0289739699.SGD","BK4585","IBB","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672715686","title":"Major Drugmakers Turn to China for Licensing Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2672715686","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672715686?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:50","pubTimestamp":1790934645,"startTime":"0","endTime":"0","summary":"FACTBOX-Major drugmakers turn to China for licensing dealsOct 2 (Reuters)-Abogen said on Friday it has signed a licensing deal worth up to $7.8 billion with Swiss drugmaker NovartisNOVN.Sto develop an","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nL4N45O0HV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","SG9999014880.SGD","IE00BFXG1179.USD","KURE","BK1587","LU2023250504.SGD","LU2293690249.USD","IE00B1BXHZ80.USD","LU0827474353.SGD","SG9999015945.SGD","LU0784383803.USD","LU1366192091.USD","LU0124676726.USD","LU1481599808.USD","IE00B19Z3581.USD","LU0320765646.SGD","IE00B3PB1722.GBP","LU2750360997.AUD","BK4551","LU0390134368.USD","LU1035775433.USD","LU1487256676.USD","LU0661504455.SGD","LU0348827113.USD","LU1280957306.USD","LU1267930227.SGD","LU2361044949.HKD","LU2399975544.HKD","LU0057025933.USD","LU0106261372.USD","LU0306806265.USD","LU2125909593.SGD","LU1670628061.USD","IE00B543WZ88.USD","BK0239","MHIP","LU0501845795.SGD","LU2433249047.HKD","BK4592","LU2488822045.USD","HCM","LU1883839398.USD","LU0348784397.USD","LU0353189680.USD","LU0965508806.USD","IE0005OL40V9.USD","LU0887340254.USD","LU0203345920.USD","LU0321505439.SGD","ILDR","LU1732799900.SGD","LU1302929846.USD","LU0820561818.USD","LU0203201768.USD","LU0889566641.SGD","600276","LU0348825331.USD","LU1051770623.HKD","LU1496350171.SGD","SG9999014559.SGD","LU2097828557.USD","BK0196","LU0969580561.USD","LU0417516738.SGD","LU1496350502.SGD","LU2168564495.EUR","IXJ","VHT","LU0526926950.USD","LU0244354667.USD","01093","LU0079474960.USD","LU1328277881.USD","LU2462157665.USD","LU0354030438.USD","LU1188198961.HKD","IE00B42XCP33.USD","LU0882574139.USD","LU2097828474.EUR","SGXZ31699556.SGD","LU1781817850.SGD","IE00BLSP4239.USD","LU0708994859.HKD","LU1934455277.USD","BK4568","LU2539964713.USD","LU1718418525.SGD","LU0889565916.HKD","LU0128525929.USD","LU1997245094.SGD","IE00BKDWB100.SGD","LU0964806797.USD","LU2360032135.SGD","NVOH","IE0008369823.USD","NVO","IYH","LU1226287529.USD","LU2108987350.USD","LU0211331839.USD","LU0011850046.USD","LU1868836591.USD","LU2289578879.USD","NVOX","SG9999002232.USD","IE00BZ1G4Q59.USD","LU1153584641.USD","LU0943347566.SGD","SG9999001440.SGD","SG9999001176.USD","LU0289961442.SGD","LU0047473722.SGD","LU1969619763.USD","IE00BDGV0183.EUR","LU2324357040.USD","IE00B031HY20.USD","IE00BK4W5M84.HKD","LU2168564222.USD","ELIL","LU1064131003.USD","IHE","LU0211326755.USD","LU2495084118.USD","LU0980610538.SGD","LU0353189763.USD","LU1989772840.SGD","LU1839511570.USD","LU0345777659.USD","HRTS","LU0964807845.USD","LU0640478417.SGD","LU0225284248.USD","LU2063271972.USD","IE00B2B36J28.USD","LU0965509283.SGD","LU2091194634.USD","LU2552382058.USD","LU1551013425.SGD","IE00BFTCPJ56.SGD","LU2461242641.AUD","SGXZ57979304.SGD","IE0002141913.USD","BK4559","LU0053666078.USD","LU2646069778.SGD","IBBQ","LU0823434740.USD","LU1670627923.USD","LU2756315318.SGD","LU2028103732.USD","LU1960683339.HKD","LU2125154778.USD","BK1589","BK1588","LU0348767384.USD","LU0061475181.USD","IE00BKPKM643.USD","LU1003076772.USD","BK4578","LU0784385840.USD","LU0114720955.EUR","LU0405327148.USD","LU0234570918.USD","LU0784385170.HKD","LU1226288253.USD","IE0008368742.USD","LU0256863811.USD","LU0949170772.SGD","BK0028","PPH","GLAM","LU2355687059.USD","LU1894683264.USD","LU1988902786.USD","SG9999015358.SGD","LU0472753341.HKD","LU1032466523.USD","IE000BZT7R73.USD","LU1145028129.USD","LU2097828805.USD","LU0976567544.SGD","LU2491049909.HKD","LU1670711040.USD","SG9999015986.USD","LU1046234339.USD","688331","LU0502904849.HKD","LU0405327494.USD","LU1868836914.USD","LU0171276677.USD","LU1236620750.USD","LU0634319403.HKD","LU1997244956.HKD","SG9999011175.SGD","LU2129689605.HKD","IE00BJT1NW94.SGD","LU0348766576.USD","LU0432979614.USD","LU1400636574.HKD","LU1228905540.USD","LU1309081286.SGD","REGN","MEDI","BK4585","IE00BLSP4452.SGD","LU2125909247.SGD","LU2242646821.SGD","SG9999017495.SGD","LU0237698245.USD","IE00BWXC8680.SGD","LU0912757837.SGD","LU1023059063.AUD","LU1153585028.USD","688506","LU1993786604.SGD","LU1894683348.USD","LU0130517989.USD","LU0069063385.USD","IE00B3M56506.USD","LU1228905037.USD","LU1064927863.SGD","LU0345770308.USD","LU1244550221.USD","LU1941712264.USD","LU1655091616.SGD","GSK.UK","LU1355424745.HKD","LU1863844749.USD","TMED","BK5011","BK0183","LU2750360641.GBP","SGXZ51526630.SGD","LU0047473722.EUR","LU0072913022.USD","LU2237443549.SGD","LU0545562505.USD","LU2596442595.SGD","LU2471134879.HKD","LU2293690082.USD","IE0002270589.USD","LU0162691827.USD","IE00BZ08YS42.EUR","LU0354030511.USD","LU0154236417.USD","LU0267386448.USD","LU1863844665.USD","LU0757432116.USD","LU2089283258.USD","LU2357627491.SGD","LU0067412154.USD","LU0965509101.SGD","LU1580142542.USD","LLY","LU0795875086.SGD","LU1868837300.USD","IE00BWDBJ516.SGD","LU1623119135.USD","IE00BK4W5L77.USD","LU1226287875.USD","LU0320765992.SGD","LU0456855351.SGD","LU2362540622.SGD","SG9999014906.USD","AGNG","LU0972486137.USD","LU1003077747.HKD","LU1481600234.SGD","MRK","LU0070302665.USD","CURE","LU1069347547.HKD","LU1255011170.USD","LU0861579265.USD","LU0640476718.USD","LU0557290698.USD","LU3187612489.SGD","LU2129689514.USD","LU1923622614.USD","LU1084165304.USD","IE00B4JS1V06.HKD","BNTX","LU2476274308.USD","LU1201861249.SGD","LU2148510915.USD","PJP","XLV","LU0256863902.USD","LU2242652126.USD","LU0689472784.USD","LU1720051108.HKD","LU1244550577.SGD","LU0868494617.USD","SG9999015952.SGD","LU2097828631.EUR","LU2237443382.USD","LU1291159041.SGD","LU0942090050.USD","LU2111349929.HKD","IE00BBT3K403.USD","LU0310800379.SGD","LU2023250843.SGD","LU1267930490.SGD","LU0345777147.USD","LU1699723380.USD","LU0320765059.SGD","IE00B4R5TH58.HKD","LU0109394709.USD","SG9999003800.SGD","LU2746668974.SGD","LU0316494557.USD","LU2039709279.SGD","SG9999018865.SGD","03692","IE000M9KFDE8.USD","LU2089984988.USD","LU0098860793.USD","LU0133085943.USD","ABBV","LU1941712348.USD","LU1983299246.USD","LU1273509221.SGD","BK4139","LU1670711123.USD","RHHBY","BK4535","LU1116320901.HKD","LU2756315664.SGD","LU0266013472.USD","SG9999001176.SGD","LU2362541513.USD","LU1037948897.HKD","LU2456880835.USD","LU2087625088.SGD","BK1515","LU2129689431.USD","LU1152091754.HKD","LU0161305163.EUR","LU0130102774.USD","IE000WAW04H5.SGD","LU0052756011.USD","LU1820825898.SGD","LU0499090636.EUR","SG9999014567.USD","FTXH","LU0265550946.USD","LU0171293334.USD","LLII","LU2476274720.SGD","LU0868494708.USD","BK1521","LU1548497426.USD","LU1880407215.USD","LU2471134796.USD","SGXZ99366536.SGD","BK4533","LU2211815571.USD","RXL","LU2552382215.SGD","LU1629891620.HKD","IE00BKPKM429.USD","LU1712237335.SGD","LU1814569148.SGD","SG9999004220.SGD","LU1008478684.HKD","LU1116320737.USD","TRUH","IE00BFSS7M15.SGD","LU1226287792.SGD","MEDX","LU2328871848.SGD","LU1267930813.SGD","LU1104425308.USD","LU0417517546.SGD","LU0203347892.USD","LU0077335932.USD","IE00BZ08YT58.USD","LU0210536198.USD","LU0238689110.USD","LU1261432733.SGD","LU0385154629.USD","LU0882574055.USD","LU1934455194.USD","IE0009355771.USD","LU0820561909.HKD","BK1593","BK4566","LU2133065610.SGD","LU2746668461.USD","LU0158827781.USD","LU2491050154.USD","HK0000165453.HKD","LU1585245621.USD","LU1098665638.USD","IE0000B7K699.USD","LU1670710588.SGD","IE00B7KXQ091.USD","LU0889565080.SGD","LU2023250330.USD","01276","LU0820562030.AUD","LU2097828714.EUR","LU0029864427.USD","LU2279689827.SGD","LU1831875114.USD","BK1161","LU0058720904.USD","LU1035773651.USD","LU1064130708.USD","LU0225771236.USD","LU0471298694.HKD","LU0553294199.USD","LU0607220059.USD","BK1574","IE00BGHQF631.EUR","LU0466842654.USD","LU0211328371.USD","SG9999002224.SGD","LU2242644610.SGD","SG9999014575.USD","LU0823434583.USD","LU0672654240.SGD","LU2347655073.USD","AZN.UK","LU2023251221.USD","LU2168564065.EUR","LU0128525689.USD","LU1328615791.USD","LU0289739699.SGD","LU2357305700.SGD","LU2360106947.USD","IE0004445239.USD","LU0109391861.USD","LU1226288170.HKD","LU0198837287.USD","LU0823399737.USD","LU1267930730.SGD","IE0001KFT4U8.USD","IE00BJJMRZ35.SGD","LLYZ","PFE","LU0648001328.SGD","LU0997586432.USD","LU1400636657.SGD","LU0314109678.HKD","LU2087621335.USD","GDOC","LU0708995401.HKD","LU1400636491.USD","01530","LU2271345857.HKD","LU0158827948.USD","LU0149534421.HKD","LU0315179316.USD","LU0985320562.USD","LU1232071149.USD","BK0188","LU1720051017.SGD","LU2106854487.HKD","LU1794554557.SGD","LU0072461881.USD","LU0987226296.USD","LU1974910355.USD","BK4588","LU1152091168.USD","LU0211326839.USD","LU1807302812.USD","LU1037948541.HKD","LU0957799991.USD","BK0060","LU0786609619.USD","LU1934455863.HKD","LU0348783233.USD","LU0140636845.USD","LU1035777561.USD","LU0006306889.USD","LU0265550359.USD","LU1691799644.USD","LU1829250122.USD","IE00BZ08YR35.GBP","IE00BJLML261.HKD","LU2347655156.SGD","LU2168563687.JPY","ELIS","LU0857590862.USD","LU1551013342.USD","LU0540923850.HKD","LU0792757196.USD","LU1093756325.SGD","LU2168564149.EUR","LU0880133367.SGD","LU1127390331.HKD","IE000SO60NU8.SGD","LU0738911758.USD","IE0004445015.USD","LU1066051225.USD","LU0575583348.USD","LU1301847155.USD","LU2237443465.HKD","LLYX","IE00BFSS8Q28.SGD","LU1202635105.USD","LU1066051498.USD","LU2114397693.USD","LU1146622755.USD","LU0094547139.USD","LU0920783379.SGD","IE00BKVL7J92.USD","LU0174119429.USD","LU1917777945.USD","LU0463099449.HKD","LU2264538146.SGD","LU2237443622.USD","LU1720050803.USD","LU2361045086.USD","LU0455707207.USD","BK4516","LU0289739343.SGD","LU0096364046.USD","LU1670756490.USD","LU0545039389.USD","IE000MB6IJN5.SGD","LU0097036916.USD","LU1323610961.USD","LU0225283273.USD","09995","LU0109981661.USD","LU0170899867.USD","BK4007","LU1078025761.USD","SG9999018857.SGD","LU1069344957.HKD","LU2236285917.USD","LU0960981461.USD","LU0949170426.SGD","LU2468319806.SGD","IE00B5MMRT66.SGD","IE00BVYPNW00.USD","LU1019632923.USD","LU1066053197.SGD","LU1015430645.USD","IE00BQJZX424.USD","01801","LU1066051811.HKD","WDNA","LU1868837136.USD","IBB","IE000F7OJYX1.SGD","CANC","BK1191","OZEM","LU1645745479.HKD","LU0471298777.SGD","LU2778985437.USD","LU1929549753.HKD","LU1430594728.SGD","THNR","IE00BN8TJ469.HKD","LU1989771016.USD","LU0920840948.USD","BK4550","LU1061106388.HKD","LU1997245177.USD","IE00B19Z3B42.SGD","SG9999013999.USD","LU1074936037.SGD","SGXZ81514606.USD","03933","LU0310799852.SGD","LU0965509010.AUD","LU1236620834.HKD","LU0234572021.USD","LU0689626769.HKD","LU0208291251.USD","NVOC","BK4534","LU0395794307.EUR","LU0417516902.SGD","LU1244550494.USD","BBH","LU0320765489.SGD","LU1732800096.USD","SG9999014898.SGD","LU2112291526.USD","LU1813983027.USD","LU1119994496.HKD","LU1046248800.SGD","LU1162221912.USD","LU0823416689.USD","LU1196032939.SGD","LU1093756168.USD","LU0787776722.HKD","LU1019634622.SGD","02096","GB00BDT5M118.USD","IE00BVYPNV92.GBP","LU0971552830.HKD","LU0795875169.SGD","LU0971552673.USD","LU0211327993.USD","LU0496365809.HKD","SG9999015978.USD","BK0012","LU1064131342.USD","LU2580892862.HKD","IE00B3T34201.USD","LU1880407132.USD","SG9999014542.SGD","03165","LU1989772923.USD","BK4532","LU2265009873.SGD","PAWZ","LU0511384066.AUD","IE00B775H168.HKD","BMED","BK1583","LU2602419157.SGD","IE00BJJMRX11.SGD","LU2580892789.USD","LU0683600562.USD","SG9999014914.USD","BK4599","IE00B1XK9C88.USD","IE00BPRC5H50.USD","SG9999015341.SGD","LU2237443978.SGD","LU0985481810.HKD","LU2471134523.USD","BMY","LU0417516571.SGD","LU0326950275.SGD","LU2417539215.USD","LU2462591350.SGD","LU2361044865.SGD","LU1170363599.USD","LU0561508036.HKD","LU1868836757.USD","LU1670710661.SGD","SMMT","LU0963555726.SGD","00013","LU2896262040.SGD","LU1961090484.USD","LU1979441026.SGD","LU0997586515.USD","LU2237438978.USD","LU1804176565.USD","IE00BN29S564.USD","IE0034235071.USD","LU0203202063.USD","LU0323591593.USD","LU0784384876.USD","LU2089284900.SGD","LU2237443895.HKD","BK4548","LU1571399168.USD","LU0321505868.SGD","NVS","LU0306807586.USD","IE00BSNM7G36.USD","09926","LU2213496289.HKD","LU1951186391.HKD","LU2471134952.CNY","LU0477156953.USD","BK4581","LU0726765562.USD","FHLC","LU0348735423.USD","TBXU","IE0034235188.USD","LU0345770993.USD","LU0310800965.SGD","JDOC","LU2125154935.USD","LU0859254822.USD","LU2362541273.HKD","LU2491050071.SGD","LU2552382132.HKD","LU0122379950.USD","LU1267930573.SGD","IE00BJJMRY28.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672137097","title":"Sanofi, Regeneron's Dupixent Successors Might Fall Short of Rivals","url":"https://stock-news.laohu8.com/highlight/detail?id=2672137097","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672137097?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:35","pubTimestamp":1790933700,"startTime":"0","endTime":"0","summary":"0934 GMT - Sanofi and Regeneron Pharmaceuticals' potential successors to blockbuster medicine Dupixent might lag behind rival drugs Pfizer and AbbVie are developing, Citi analysts say in a research note. The new experimental drugs Sanofi and Regeneron will jointly develop under their alliance focus solely on extending the dosing interval of Dupixent without compromising efficacy or tolerability, but there is no expectation of a superior performance, Citi says. This suggests those medicines might struggle to compete with Pfizer's tilrekimig and AbbVie's zumilokibart, both of which have shown potential for better efficacy in midstage trials, according to Citi. Moreover, it might be challenging for Sanofi and Regeneron to get reimbursement for those drugs from healthcare payers after copycat versions of Dupixent become available, the analysts add. Sanofi shares fall 3.4%.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053666078.USD","LU0211327993.USD","LU2106854487.HKD","LU0965509283.SGD","ABBV","JDOC","LU1037948541.HKD","IXJ","TBXU","PJP","LU0098860793.USD","LU0795875169.SGD","IBBQ","LU0949170772.SGD","VHT","LU2112291526.USD","XLV","LU0158827948.USD","LU1244550577.SGD","SNY","FTXH","GLAM","SNYNF","LU0069063385.USD","LU0057025933.USD","MEDX","LU1720051108.HKD","AGNG","BBH","FHLC","TRUH","LU1883839398.USD","BK4585","LU0417517546.SGD","IE00BJT1NW94.SGD","REGN","OZEM","LU0128525929.USD","LU2347655073.USD","BK4599","IBB","LU1917777945.USD","IYH","LU0029864427.USD","LU0203347892.USD","PPH","PFE","LU2133065610.SGD","RXL","LU1057294990.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672713007","title":"Analysts’ Top Healthcare Picks: Regeneron (REGN), Idexx Laboratories (IDXX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672713007","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672713007?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:20","pubTimestamp":1790932825,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Regeneron (REGN) and Idexx Laboratories (IDXX) with ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-regeneron-regn-idexx-laboratories-idxx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-regeneron-regn-idexx-laboratories-idxx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","BK4082","GB00B4LPDJ14.GBP","LU0690374615.EUR","GB00B4QBRK32.GBP","LU0170899867.USD","BK4581","LU0345774391.USD","LU1941712264.USD","LU2362540622.SGD","LU0823434583.USD","TBXU","BK4567","LU1974910355.USD","PAWZ","BK4137","LU2468319806.SGD","XBI","LU0029874061.USD","LU0320765992.SGD","LU1917777945.USD","LU2404859741.USD","LU2362541273.HKD","LU2106854487.HKD","LU2237438978.USD","IBBQ","LU0289739699.SGD","LU0823434740.USD","LU0114720955.EUR","XLV","LU0823416689.USD","LU0128526141.USD","BK4139","BK4504","LABU","LU2023250504.SGD","LU0345774631.USD","LU2404859667.USD","LU1989771016.USD","IBB","BBH","LU0882574055.USD","LU0053666078.USD","BK4588","HCSG","REGN","LU1941712348.USD","LU2324357040.USD","LU2089984988.USD","IDXX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672713165","title":"Vertex Minerals lodges 2026 corporate governance statement with ASX","url":"https://stock-news.laohu8.com/highlight/detail?id=2672713165","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672713165?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:08","pubTimestamp":1790932081,"startTime":"0","endTime":"0","summary":"The latest update is out from Vertex Minerals Ltd. ( ($AU:VTX) ). Vertex Minerals Ltd. has lodged its Appendix 4G and 2026 Corporate Governance Sta...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-lodges-2026-corporate-governance-statement-with-asx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-lodges-2026-corporate-governance-statement-with-asx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NUSC","EXEQ","SGXZ57979304.SGD","BK4139","IE00B2B36J28.USD","IE00B4R5TH58.HKD","MDCP","JSTC","DSI","BIB","SSPX","VRTX","GNMX","IE0002270589.USD","BK4585","VERX","TBXU","LU1778281490.HKD","SUSA","LU2417539215.USD","CVLC","LU0320765992.SGD","CHRI","ESGV","IE00B19Z3B42.SGD","LU0432979614.USD","HAPI","IBB","CDEI","LOPP","VOTE","BBH","ESGA","SG9999001176.USD","PEMX","ESML","NUDV","SG9999013999.USD","LU1035775433.USD","MTX","BK4567","LU0256863811.USD","HAPY","ESGY","PBE","IBBQ","ESG","IE00BJJMRZ35.SGD","IDNA","FDRX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}